Tangeretin stimulates glucose uptake via regulation of AMPK signaling pathways in C2C12 myotubes and improves glucose tolerance in high-fat diet-induced obese mice

Molecular and Cellular Endocrinology

Volumn 358, Issue 1, 2012, Pages 127-134

  Kim, Myung Sunny ^a   Hur, Haeng Jeon ^a   Kwon, Dae Young ^a   Hwang, Jin Taek ^a  

^a Korea Food Research Institute   (South Korea)

Author keywords

AMP activated protein kinase; Anti diabetic; C2C12 myotube; High fat diet; Tangeretin

Indexed keywords

ADIPONECTIN; CHOLESTEROL; GLUCOSE; GLUCOSE TRANSPORTER 4; INTERLEUKIN 6; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; RESISTIN; SMALL INTERFERING RNA; TANGERETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CELL MEMBRANE; CHOLESTEROL BLOOD LEVEL; CYTOKINE RELEASE; CYTOSOL; DOSE RESPONSE; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HYPERCHOLESTEROLEMIA; INSULIN SENSITIVITY; LIPID DIET; LIPID STORAGE; MOUSE; MYOTUBE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; WEIGHT GAIN;

4-CHLORO-7-NITROBENZOFURAZAN; ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; CELL LINE; CHEMOKINE CCL2; DEOXYGLUCOSE; DIABETES MELLITUS; DIET, HIGH-FAT; DNA-BINDING PROTEINS; FLAVONES; GLUCOSE; GTPASE-ACTIVATING PROTEINS; HEK293 CELLS; HUMANS; INTERLEUKIN-6; LEPTIN; MICE; MICE, INBRED C57BL; MICE, OBESE; MUSCLE FIBERS, SKELETAL; PHOSPHORYLATION; PPAR GAMMA; RESISTIN; RETINOID X RECEPTOR ALPHA; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 84860483730     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.03.013     Document Type: Article

References (36)

1. Arafa E.S.A., Zhu Q., Barakat B.M., Wani G. Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. Cancer Res. 2009, 69:8910-8917.
2. Arai M., Uchiba M., Komura H., Mizuochi Y., Harada N., Okajima K. Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. J. Pharmacol. Exp. Ther. 2010, 334:206-213.
3. Bertrand L., Ginion A., Beauloye C., et al. AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H239-H250.
4. Bracke M.E., Vyncke B.M., Van Larebeke N.A., Bruyneel E.A. The flavonoid tangeretin inhibits invasion of MO4 mouse cells into embryonic chick heart in vitro. Clin. Exp. Metastasis 1989, 7:283-300.
5. Breinholt V., Lauridsen S.T., Dragsted L.O. Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat. Xenobiotica 1999, 29:1227-1240.
6. Buler M., Aatsinki S.M., Skoumal R., et al. Energy-sensing factors coactivator peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) and AMP-activated protein kinase control expression of inflammatory mediators in liver: induction of interleukin 1 receptor antagonist. J. Biol. Chem. 2012, 287:1847-1860.
7. Cheng Z., Surichan S., Ruparelia K., Arroo R., Boarder M.R. Tangeretin and its metabolite 4'-hydroxytetramethoxyflavone attenuate EGF-stimulated cell cycle progression in hepatocytes; role of inhibition at the level of mTOR/p70S6K. Br. J. Pharmacol. 2011, 162:1781-1791.
8. Choi S.Y., Ko H.C., Ko S.Y., Hwang J.H. Correlation between flavonoid content and the NO production inhibitory activity of peel extracts from various citrus fruits. Biol. Pharm. Bull. 2007, 30:772-778.
9. Ferré P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 2004, 53:S43-S50.
10. Hardie D.G. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int. J. Obes. 2008, 32:S7-S12.
11. Hardie D.G. Energy sensing by the AMP-activated protein kinase and its effects on muscle metabolism. Proc. Nutr. Soc. 2011, 70:92-99.
12. Hou X., Xu S., Maitland-Toolan K.A., et al. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem. 2008, 283:20015-20026.
13. Ishii K., Tanaka S., Kagami K., Henmi K. Effects of naturally occurring polymethyoxyflavonoids on cell growth, p-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cells. Cancer Invest. 2010, 28:220-229.
14. Ishikura S., Koshkina A., Klip A. Small G proteins in insulin action: Rab and Rho families at the crossroads of signal transduction and GLUT4 vesicle traffic. Acta Physiol. 2008, 192:61-74.
15. Itokawa H., Morris-Natschke S.L., Akiyama T., Lee K.H. Plant-derived natural product research aimed at new drug discovery. J. Nat. Med. 2008, 62:263-280.
16. Kim J.H., Park J.M., Kim E.K., et al. Curcumin stimulates glucose uptake through AMPK-p38 MAPK pathways in L6 myotube cells. J. Cell Physiol. 2010, 223:771-778.
17. Lee W.J., Song K.H., Koh E.H., et al. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem. Biophys. Res. Commun. 2005, 332:885-891.
18. Leahy J.L. Thiazolidinediones in prediabetes and early type 2 diabetes: what can be learned about that disease's pathogenesis. Curr. Diabetes Rep. 2009, 9:215-220.
19. Lehrke M., Lazar M.A. The many faces of PPARgamma. Cell 2005, 123:993-999.
20. Liu L.Z., Cheung S.C., Lan L.L., et al. Berberine modulates insulin signaling transduction in insulin-resistant cells. Mol. Cell Endocrinol. 2010, 317:148-153.
21. O'Neill, H.M., Maarbjerg, S.J., Crane, J.D., et al., 2011. AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc. Natl. Acad. Sci. USA.108, 16092-7.
22. Ozata M., Oktenli C., Bingol N., Ozdemir I.C. The effects of metformin and diet on plasma testosterone and leptin levels in obese men. Obes. Res. 2001, 9:662-667.
23. Park C.E., Kim M.J., Lee J.H., et al. Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase. Exp. Mol. Med. 2007, 39:222-229.
24. Penumathsa S.V., Thirunavukkarasu M., Zhan L., Maulik G., Maulik G., Menon V.P., Bagchi D., Maulik N. Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. J. Cell Mol. Med. 2008, 12:2350-2361.
25. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
26. Shah A., Mehta N., Reilly M.P. Adipose inflammation, insulin resistance, and cardiovascular disease. J. Parenter. Enteral Nutr. 2008, 32:638-644.
27. Silha J.V., Krsek M., Skrha J.V., Sucharda P., Nyomba B.L., Murphy L.J. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur. J. Endocrinol. 2003, 149:331-335.
28. Takano K., Tabata Y., Kitao Y., et al. Methoxyflavones protect cells against endoplasmic reticulum stress and neurotoxin. Am. J. Physiol. Cell Physiol. 2007, 292:C353-C361.
29. Teo C.F., Wollaston-Hayden E.E., Wells L. Hexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytes. Mol. Cell Endocrinol. 2010, 318:44-53.
30. Tuñón M.J., García-Mediavilla M.V., Sánchez-Campos S., González-Gallego J. Potential of flavonoids as anti-inflammatory agents: modulation of pro-inflammatory gene expression and signal transduction pathways. Curr. Drug Metab. 2009, 10:256-271.
31. Villacorta L., Schopfer F.J., Zhang J., Freeman B.A., Chen Y.E. PPARgamma and its ligands: therapeutic implications in cardiovascular disease. Clin. Sci. 2009, 116:205-218.
32. Xu G.H., Chen J.C., Liu D.H., et al. Minerals, phenolic compounds, and antioxidant capacity of citrus peel extract by hot water. J. Food Sci. 2008, 73:C11-C18.
33. Yoon J.H., Lim T.G., Lee K.M., et al. Tangeretin reduces ultraviolet B (UVB)-induced cyclooxygenase-2 expression in mouse epidermal cells by blocking mitogen-activated protein kinase (MAPK) activation and reactive oxygen species (ROS) generation. J. Agric. Food Chem. 2011, 59:222-228.
34. Yun H., Lee J.H., Park C.E., et al. Inulin increases glucose transport in C2C12 myotubes and HepG2 cells via activation of AMP-activated protein kinase and phosphatidylinositol 3-kinase pathways. J. Med. Food. 2009, 12:1023-1028.
35. Zhang B.B., Zhou G., Li C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 2009, 9:407-416.
36. Zygmunt K., Faubert B., MacNeil J., Tsiani E. Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK. Biochem. Biophys. Res. Commun. 2010, 398:178-183.